After an FDA panel “unanimously” voted to recommend that the agency approved Novavax’s (NASDAQ:NVAX) coronavirus vaccine, the outlook of NVAX stock has significantly improved.  Nonetheless, I believe that the shares remain risky, and I recommend that only speculative, risk-tolerant investors buy them at this point. An FDA Approval Is Probably Assured, But Other Risks Remain
0 Comments
Candlestick charts are a technical tool that packs data for multiple time frames into single price bars. This makes them more useful than traditional open-high, low-close bars or simple lines that connect the dots of closing prices. Candlesticks build patterns that predict price direction once completed. Proper color coding adds depth to this colorful technical tool, which dates back to 18th-century
0 Comments
Headquartered in San Francisco, installment-payment broker Affirm (NASDAQ:AFRM) is also considered a specialist in the “buy now, pay later” (BNPL) niche market. As this market becomes increasingly crowded – and a famous tech company enters into the space – AFRM stock should be monitored but not owned. There’s nothing wrong with rooting for a small
0 Comments
Check out the companies making headlines in midday trading. Continental Resources — Shares soared 14% after the shale company announced an all-cash buyout proposal from the family trust of billionaire founder Harold Hamm. Continental Resources said it’s yet to review the offer that would take the company private in a $25.4 billion deal. FedEx —
0 Comments
Take a look at some of the biggest movers in the premarket: Continental Resources (CLR) – The oil and natural gas producer’s stock rallied 7.4% in the premarket after receiving a $70 per share “take private” bid from Chairman Harold Hamm and his family. The company’s board will establish an independent committee to evaluate the
0 Comments